Evaluation of the CCL17/CCL22-CCR4 axis in pediatrics with B-cell acute lymphoblastic leukemia before and after a chemotherapy course.
Marzieh MotaghiAbdollah JafarzadehAlireza FarsinejadAida NorouziHossein KhorramdelazadZahra FarahmandiniaAli AfgarGholamhossein HassanshahiaPublished in: Cytokine (2024)
The CCL17/CCL22-CCR4 axis can be used as a novel predictive and prognostic biomarker in B-ALL.